Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

October 31, 2013

Conditions
DyskinesiasMovement DisordersParkinson Disease
Interventions
DRUG

Levodopa (delivered intravenously)

"IV Levodopa is given from 09:00 to 11:00 am during the testing phase of the study. The IV Levodopa allows the researchers to watch one full on and off levodopa cycle while in the inpatient unit."

Trial Locations (1)

97201

VA Medical Center, Portland, Portland

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

lead

US Department of Veterans Affairs

FED

NCT00467597 - Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1) | Biotech Hunter | Biotech Hunter